If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more.
Strengthening Capacity for the Development of Theranostic Peptide Radiopharmaceuticals
Project Type
Technical Cooperation Project
TC Region
Asia and the Pacific
Project Code
IRA6012Approved Date
1 January 2022
Status
Active
Objectives
To increase life expectancy in cancer patients by strengthening capacity for the development of radiolabelled theranostic peptide radiopharmaceuticals.